Highlights

[PHARMA] YoY Quarter Result on 2013-06-30 [#2]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 16-Aug-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2013
Quarter 30-Jun-2013  [#2]
Profit Trend QoQ -     -76.32%    YoY -     -62.67%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Revenue 531,796 512,845 525,072 437,633 456,737 396,435 350,335 7.20%
  YoY % 3.70% -2.33% 19.98% -4.18% 15.21% 13.16% -
  Horiz. % 151.80% 146.39% 149.88% 124.92% 130.37% 113.16% 100.00%
PBT 21,487 25,056 24,622 9,605 27,618 19,380 20,327 0.93%
  YoY % -14.24% 1.76% 156.35% -65.22% 42.51% -4.66% -
  Horiz. % 105.71% 123.26% 121.13% 47.25% 135.87% 95.34% 100.00%
Tax -5,846 -8,414 -8,665 -3,434 -11,541 -5,335 -5,809 0.11%
  YoY % 30.52% 2.90% -152.33% 70.25% -116.33% 8.16% -
  Horiz. % 100.64% 144.84% 149.17% 59.12% 198.67% 91.84% 100.00%
NP 15,641 16,642 15,957 6,171 16,077 14,045 14,518 1.25%
  YoY % -6.01% 4.29% 158.58% -61.62% 14.47% -3.26% -
  Horiz. % 107.74% 114.63% 109.91% 42.51% 110.74% 96.74% 100.00%
NP to SH 14,995 16,217 15,975 5,865 15,713 13,920 14,747 0.28%
  YoY % -7.54% 1.51% 172.38% -62.67% 12.88% -5.61% -
  Horiz. % 101.68% 109.97% 108.33% 39.77% 106.55% 94.39% 100.00%
Tax Rate 27.21 % 33.58 % 35.19 % 35.75 % 41.79 % 27.53 % 28.58 % -0.81%
  YoY % -18.97% -4.58% -1.57% -14.45% 51.80% -3.67% -
  Horiz. % 95.21% 117.49% 123.13% 125.09% 146.22% 96.33% 100.00%
Total Cost 516,155 496,203 509,115 431,462 440,660 382,390 335,817 7.42%
  YoY % 4.02% -2.54% 18.00% -2.09% 15.24% 13.87% -
  Horiz. % 153.70% 147.76% 151.60% 128.48% 131.22% 113.87% 100.00%
Net Worth 524,177 528,477 502,293 480,568 481,394 451,517 417,065 3.88%
  YoY % -0.81% 5.21% 4.52% -0.17% 6.62% 8.26% -
  Horiz. % 125.68% 126.71% 120.44% 115.23% 115.42% 108.26% 100.00%
Dividend
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Div 12,949 18,134 10,356 8,810 8,827 - 50,261 -20.21%
  YoY % -28.59% 75.10% 17.55% -0.19% 0.00% 0.00% -
  Horiz. % 25.76% 36.08% 20.61% 17.53% 17.56% 0.00% 100.00%
Div Payout % 86.36 % 111.82 % 64.83 % 150.22 % 56.18 % - % 340.83 % -20.44%
  YoY % -22.77% 72.48% -56.84% 167.39% 0.00% 0.00% -
  Horiz. % 25.34% 32.81% 19.02% 44.07% 16.48% 0.00% 100.00%
Equity
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Net Worth 524,177 528,477 502,293 480,568 481,394 451,517 417,065 3.88%
  YoY % -0.81% 5.21% 4.52% -0.17% 6.62% 8.26% -
  Horiz. % 125.68% 126.71% 120.44% 115.23% 115.42% 108.26% 100.00%
NOSH 258,981 259,057 258,914 258,370 117,700 106,994 106,939 15.87%
  YoY % -0.03% 0.06% 0.21% 119.52% 10.01% 0.05% -
  Horiz. % 242.17% 242.25% 242.11% 241.60% 110.06% 100.05% 100.00%
Ratio Analysis
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
NP Margin 2.94 % 3.25 % 3.04 % 1.41 % 3.52 % 3.54 % 4.14 % -5.54%
  YoY % -9.54% 6.91% 115.60% -59.94% -0.56% -14.49% -
  Horiz. % 71.01% 78.50% 73.43% 34.06% 85.02% 85.51% 100.00%
ROE 2.86 % 3.07 % 3.18 % 1.22 % 3.26 % 3.08 % 3.54 % -3.49%
  YoY % -6.84% -3.46% 160.66% -62.58% 5.84% -12.99% -
  Horiz. % 80.79% 86.72% 89.83% 34.46% 92.09% 87.01% 100.00%
Per Share
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 205.34 197.97 202.80 169.38 388.05 370.52 327.60 -7.48%
  YoY % 3.72% -2.38% 19.73% -56.35% 4.73% 13.10% -
  Horiz. % 62.68% 60.43% 61.90% 51.70% 118.45% 113.10% 100.00%
EPS 5.79 6.26 6.17 2.27 13.35 13.01 13.79 -13.45%
  YoY % -7.51% 1.46% 171.81% -83.00% 2.61% -5.66% -
  Horiz. % 41.99% 45.40% 44.74% 16.46% 96.81% 94.34% 100.00%
DPS 5.00 7.00 4.00 3.41 7.50 0.00 47.00 -31.14%
  YoY % -28.57% 75.00% 17.30% -54.53% 0.00% 0.00% -
  Horiz. % 10.64% 14.89% 8.51% 7.26% 15.96% 0.00% 100.00%
NAPS 2.0240 2.0400 1.9400 1.8600 4.0900 4.2200 3.9000 -10.35%
  YoY % -0.78% 5.15% 4.30% -54.52% -3.08% 8.21% -
  Horiz. % 51.90% 52.31% 49.74% 47.69% 104.87% 108.21% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
RPS 203.57 196.32 201.00 167.53 174.84 151.76 134.11 7.20%
  YoY % 3.69% -2.33% 19.98% -4.18% 15.21% 13.16% -
  Horiz. % 151.79% 146.39% 149.88% 124.92% 130.37% 113.16% 100.00%
EPS 5.74 6.21 6.12 2.25 6.01 5.33 5.65 0.26%
  YoY % -7.57% 1.47% 172.00% -62.56% 12.76% -5.66% -
  Horiz. % 101.59% 109.91% 108.32% 39.82% 106.37% 94.34% 100.00%
DPS 4.96 6.94 3.96 3.37 3.38 0.00 19.24 -20.21%
  YoY % -28.53% 75.25% 17.51% -0.30% 0.00% 0.00% -
  Horiz. % 25.78% 36.07% 20.58% 17.52% 17.57% 0.00% 100.00%
NAPS 2.0066 2.0230 1.9228 1.8396 1.8428 1.7284 1.5965 3.88%
  YoY % -0.81% 5.21% 4.52% -0.17% 6.62% 8.26% -
  Horiz. % 125.69% 126.71% 120.44% 115.23% 115.43% 108.26% 100.00%
Price Multiplier on Financial Quarter End Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 -
Price 5.5000 7.1300 4.6100 4.4900 10.1800 5.9000 4.9800 -
P/RPS 2.68 3.60 2.27 2.65 2.62 1.59 1.52 9.90%
  YoY % -25.56% 58.59% -14.34% 1.15% 64.78% 4.61% -
  Horiz. % 176.32% 236.84% 149.34% 174.34% 172.37% 104.61% 100.00%
P/EPS 94.99 113.90 74.72 197.80 76.25 45.35 36.11 17.47%
  YoY % -16.60% 52.44% -62.22% 159.41% 68.14% 25.59% -
  Horiz. % 263.06% 315.43% 206.92% 547.77% 211.16% 125.59% 100.00%
EY 1.05 0.88 1.34 0.51 1.31 2.21 2.77 -14.92%
  YoY % 19.32% -34.33% 162.75% -61.07% -40.72% -20.22% -
  Horiz. % 37.91% 31.77% 48.38% 18.41% 47.29% 79.78% 100.00%
DY 0.91 0.98 0.87 0.76 0.74 0.00 9.44 -32.26%
  YoY % -7.14% 12.64% 14.47% 2.70% 0.00% 0.00% -
  Horiz. % 9.64% 10.38% 9.22% 8.05% 7.84% 0.00% 100.00%
P/NAPS 2.72 3.50 2.38 2.41 2.49 1.40 1.28 13.37%
  YoY % -22.29% 47.06% -1.24% -3.21% 77.86% 9.38% -
  Horiz. % 212.50% 273.44% 185.94% 188.28% 194.53% 109.38% 100.00%
Price Multiplier on Announcement Date
30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 CAGR
Date 19/08/16 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 -
Price 5.6200 5.6500 4.6200 4.6600 8.8300 5.9000 4.9500 -
P/RPS 2.74 2.85 2.28 2.75 2.28 1.59 1.51 10.43%
  YoY % -3.86% 25.00% -17.09% 20.61% 43.40% 5.30% -
  Horiz. % 181.46% 188.74% 150.99% 182.12% 150.99% 105.30% 100.00%
P/EPS 97.06 90.26 74.88 205.29 66.14 45.35 35.90 18.01%
  YoY % 7.53% 20.54% -63.52% 210.39% 45.84% 26.32% -
  Horiz. % 270.36% 251.42% 208.58% 571.84% 184.23% 126.32% 100.00%
EY 1.03 1.11 1.34 0.49 1.51 2.21 2.79 -15.29%
  YoY % -7.21% -17.16% 173.47% -67.55% -31.67% -20.79% -
  Horiz. % 36.92% 39.78% 48.03% 17.56% 54.12% 79.21% 100.00%
DY 0.89 1.24 0.87 0.73 0.85 0.00 9.49 -32.57%
  YoY % -28.23% 42.53% 19.18% -14.12% 0.00% 0.00% -
  Horiz. % 9.38% 13.07% 9.17% 7.69% 8.96% 0.00% 100.00%
P/NAPS 2.78 2.77 2.38 2.51 2.16 1.40 1.27 13.93%
  YoY % 0.36% 16.39% -5.18% 16.20% 54.29% 10.24% -
  Horiz. % 218.90% 218.11% 187.40% 197.64% 170.08% 110.24% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

238  634  569  1010 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.15-0.25 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.965-0.035 
 DGSB 0.225+0.01 
 HWGB 0.77+0.055 
 DATAPRP 0.195-0.025 
 MTOUCHE 0.05-0.005 
 VC 0.045-0.01 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS